AI assistant
BRUKER CORP — Director's Dealing 2023
May 10, 2023
31067_dirs_2023-05-10_7a3672bc-6a68-4ffb-b9d9-0f8e4b14bca9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BRUKER CORP (BRKR)
CIK: 0001109354
Period of Report: 2023-05-08
Reporting Person: LAUKIEN FRANK H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-08 | Common Stock | S | 81745 | $76.99 | Disposed | 38352034 | Direct |
| 2023-05-08 | Common Stock | S | 6832 | $77.71 | Disposed | 38262287 | Direct |
| 2023-05-08 | Common Stock | S | 441 | $78.53 | Disposed | 38210993 | Direct |
| 2023-05-09 | Common Stock | S | 30359 | $74.44 | Disposed | 38180634 | Direct |
| 2023-05-09 | Common Stock | S | 70598 | $75.39 | Disposed | 38110036 | Direct |
| 2023-05-09 | Common Stock | S | 10025 | $76.12 | Disposed | 38100011 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1046499 | Indirect |
| Common Stock | 337087 | Indirect |
| Common Stock | 336607 | Indirect |
| Common Stock | 201702 | Indirect |
| Common Stock | 71728 | Indirect |
| Common Stock | 492 | Indirect |
Footnotes
F1: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.50 to $77.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $78.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $78.53, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.925 to $74.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.92 to $75.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.92 to $76.31, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F8: The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.